Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP604364.RAPf4jHzI57c85MPnNbs60KsSxF7rm2HKF7yzwCACSh40130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP604364.RAPf4jHzI57c85MPnNbs60KsSxF7rm2HKF7yzwCACSh40130_assertion type Assertion NP604364.RAPf4jHzI57c85MPnNbs60KsSxF7rm2HKF7yzwCACSh40130_head.
- NP604364.RAPf4jHzI57c85MPnNbs60KsSxF7rm2HKF7yzwCACSh40130_assertion description "[Introduction of synthetic miR-593* suppressed PLK1 expression by 69-73%, reduced cell proliferation (p = 0.008) and increased cell proportion of G2/M phase (p = 0.01) in HSA/c (an EC cells), whereas a miR-593* inhibitor upregulated PLK1 expression by 11-55%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP604364.RAPf4jHzI57c85MPnNbs60KsSxF7rm2HKF7yzwCACSh40130_provenance.
- NP604364.RAPf4jHzI57c85MPnNbs60KsSxF7rm2HKF7yzwCACSh40130_assertion evidence source_evidence_literature NP604364.RAPf4jHzI57c85MPnNbs60KsSxF7rm2HKF7yzwCACSh40130_provenance.
- NP604364.RAPf4jHzI57c85MPnNbs60KsSxF7rm2HKF7yzwCACSh40130_assertion SIO_000772 21170987 NP604364.RAPf4jHzI57c85MPnNbs60KsSxF7rm2HKF7yzwCACSh40130_provenance.
- NP604364.RAPf4jHzI57c85MPnNbs60KsSxF7rm2HKF7yzwCACSh40130_assertion wasDerivedFrom befree-20150227 NP604364.RAPf4jHzI57c85MPnNbs60KsSxF7rm2HKF7yzwCACSh40130_provenance.
- NP604364.RAPf4jHzI57c85MPnNbs60KsSxF7rm2HKF7yzwCACSh40130_assertion wasGeneratedBy ECO_0000203 NP604364.RAPf4jHzI57c85MPnNbs60KsSxF7rm2HKF7yzwCACSh40130_provenance.